These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 462479)

  • 1. Effects of verapamil on the contractile force in the glycerinated dog heart muscles.
    Maruyama Y; Ishide N; Okayama H; Ino-Oka E; Takishima T
    Tohoku J Exp Med; 1979 Jun; 128(2):199-200. PubMed ID: 462479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Ca antagonist on the contractile force in glycerinated dog heart muscles.
    Maruyama Y; Okayama H; Ishide N; Takishima T
    Pflugers Arch; 1982 Oct; 395(1):49-54. PubMed ID: 7177771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of regional myocardial ischemia on series elastic and contractile elements of glycerinated heart muscle in dogs.
    Maruyama Y; Fischer R; Bing RJ
    Jpn Circ J; 1980 Jun; 44(6):449-60. PubMed ID: 7401274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of extracellular calcium on heart muscle energetics: effects of verapamil.
    Ponce-Hornos JE; Musi EA; Bonazzola P
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H64-72. PubMed ID: 2301615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of optical isomers of verapamil on SA nodal pacemaker activity and contractility of the isolated dog heart.
    Chiba S; Kobayashi M; Furukawa Y
    Jpn Heart J; 1978 May; 19(3):409-14. PubMed ID: 691275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pentobarbital, verapamil and manganese on the frequency-force relationship of the isolated atrium and ventricle of the dog heart.
    Chiba S
    Eur J Pharmacol; 1976 Dec; 40(2):225-32. PubMed ID: 991933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between cardiac cyclic AMP and myocardial contractility induced by verapamil, calcium and magnesium ions.
    Hess ME; Gabel BE
    Cardiology; 1979; 64(2):75-86. PubMed ID: 219956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
    Endoh M; Yanagisawa T; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of alcohol on active and passive stiffness, and on isometric contractions of glycerinated heart muscle in rats.
    Maruyama Y; Bing RJ; Sarma JS; Weishaar R
    Jpn Heart J; 1978 Jul; 19(4):513-21. PubMed ID: 731876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of verapamil of frequency-force relationship in isolated dog left ventricular muscle.
    Chiba S
    Jpn J Pharmacol; 1977 Feb; 27(1):175-7. PubMed ID: 864879
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
    Cremers B; Flesch M; Südkamp M; Böhm M
    J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabain-induced negative frequency-force relationship in the isolated, blood-perfused dog atrium.
    Furukawa Y; Saegusa K; Chiba S
    Jpn Heart J; 1986 Mar; 27(2):223-32. PubMed ID: 3723800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and inotropic effects of verapamil in perfused rat heart.
    Hess ME; Shanfeld J; Levine NR
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():81-8. PubMed ID: 174169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The marked myocardial depressant effect of verapamil.
    Tzivoni D; Merin G; Eimerl D; Raz S; Gotsman MS
    Isr J Med Sci; 1978 Sep; 14(9):933-40. PubMed ID: 721421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog.
    Satoh K; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1980; 2(3):309-18. PubMed ID: 6156328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil abolishes exercise-induced regional contractile dysfunction in dogs.
    Schneider W; Ehrendorfer S; Krumpl G; Mayer N; Raberger G
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):103-10. PubMed ID: 3361978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle.
    Himori N; Ono H; Taira N
    Jpn J Pharmacol; 1976 Aug; 26(4):427-35. PubMed ID: 1003699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.